Wei-min Chung
Taitung, TNQ 40403, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction.
Journal: Scientific reports
Published: July 09, 2021
Androgen/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials.
Journal: International journal of molecular sciences
Published: May 18, 2021
LDLR-mediated lipidome-transcriptome reprogramming in cisplatin insensitivity.
Journal: Endocrine-related cancer
Published: November 25, 2019
Preclinical evaluation of exemestane as a novel chemotherapy for gastric cancer.
Journal: Journal of cellular and molecular medicine
Published: March 20, 2019
Increase Paclitaxel Sensitivity to Better Suppress Serous Epithelial Ovarian Cancer via Ablating Androgen Receptor/Aryl Hydrocarbon Receptor-ABCG2 Axis.
Journal: Cancers
Published: January 09, 2019
Ligand-independent androgen receptors promote ovarian teratocarcinoma cell growth by stimulating self-renewal of cancer stem/progenitor cells.
Journal: Stem cell research
Published: October 04, 2013
Non-genomic estrogen/estrogen receptor α promotes cellular malignancy of immature ovarian teratoma in vitro.
Journal: Journal of cellular physiology
Published: August 24, 2013
Androgen receptor increases CD133 expression and progenitor-like population that associate with cisplatin resistance in endometrial cancer cell line.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: August 22, 2013
MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro.
Journal: Stem cell research & therapy
Published: January 25, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026